** Shares of MedAdvisor MDR.AX rise 30% to A$0.13, hitting their highest levels since March 5
** The pharmaceutical co says it received a non-binding letter of intent (LOI) from a listed multinational software business with operations in Australia
** The LOI outlines a proposal to acquire the company's ANZ business division for cash - co
** It did not reveal any other details of the LOI
** Stock is biggest percentage gainer in the ASX All Ordinaries Index .AORD
** Over 1 million shares change hands, vs the 30-day average of almost 700,000
** Stock rose as much as 65% earlier in the day, marking its biggest intraday gain since March 10, 2020
** MDR stock down 55.6%, YTD
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。